Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous 18F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer? [HEAD & NECK]
CONCLUSIONS:
Gadolinium chelate contrast administration showed no added value for accurate characterization of head and neck primary tumor extension and could possibly be avoided in the PET/MR imaging head and neck workflow.
Source: American Journal of Neuroradiology - Category: Radiology Authors: Pyatigorskaya, N., De Laroche, R., Bera, G., Giron, A., Bertolus, C., Herve, G., Chambenois, E., Bergeret, S., Dormont, D., Amor-Sahli, M., Kas, A. Tags: HEAD & amp; NECK Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Head and Neck Cancer | Neurology | Neurosurgery | Nuclear Medicine | Radiology | Study